Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Nanocovax
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Recipient : The Translational Health Science and Technology Institute
Deal Size : Undisclosed
Deal Type : Collaboration
Details : THSTI has entered into a research collaboration with Nanogen Pharmaceutical, which is developing a new vaccine for COVID-19 named Nano Covax which is the first Covid-19 vaccine to be approved by Vietnam’s Ministry of Health to conduct clinical trial in...
Brand Name : Nanocovax
Molecule Type : Vaccine
Upfront Cash : Undisclosed
September 27, 2021
Lead Product(s) : Nanocovax
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Recipient : The Translational Health Science and Technology Institute
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?
Reset All
